1. CMU Intellectual Repository

Browsing by Author Carole L. Wallis

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)
17-Jul-2012Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settingsJohn A. Bartlett; Heather J. Ribaudo; Carole L. Wallis; Evgenia Aga; David A. Katzenstein; Wendy S. Stevens; Michael R. Norton; Karin L. Klingman; Mina C. Hosseinipour; John A. Crump; Khuanchai Supparatpinyo; Sharlaa Badal-Faesen; Beatrice A. Kallungal; Nagalingeswaran Kumarasamy
15-Jun-2013Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out stavudineMichele W. Tang; Soo Yon Rhee; Silvia Bertagnolio; Nathan Ford; Susan Holmes; Kim C. Sigaloff; Raph L. Hamers; Tobias F.Rinke De Wit; Herve J. Fleury; Phyllis J. Kanki; Kiat Ruxrungtham; Claudia A. Hawkins; Carole L. Wallis; Wendy Stevens; Gert U. Van Zyl; Weerawat Manosuthi; Mina C. Hosseinipour; Nicole Ngo-Giang-Huong; Laurent Belec; Martine Peeters; Avelin Aghokeng; Torsak Bunupuradah; Sherri Burda; Patricia Cane; Giulia Cappelli; Charlotte Charpentier; Anoumou Y. Dagnra; Alaka K. Deshpande; Ziad El-Katib; Susan H. Eshleman; Joseph Fokam; Jean Chrysostome Gody; David Katzenstein; Donato D. Koyalta; Johnstone J. Kumwenda; Marc Lallemant; Lutgarde Lynen; Vincent C. Marconi; Nicolas A. Margot; Sandrine Moussa; Thumbi Ndung'U; Phillipe N. Nyambi; Catherine Orrell; Jonathan M. Schapiro; Rob Schuurman; Sunee Sirivichayakul; Davey Smith; Maria Zolfo; Michael R. Jordan; Robert W. Shafer
1-Jan-2020Pharmacokinetics and Drug-Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of GenotypingKamunkhwala Gausi; Lubbe Wiesner; Jennifer Norman; Carole L. Wallis; Carolyne Onyango-Makumbi; Tsungai Chipato; David W. Haas; Renee Browning; Nahida Chakhtoura; Grace Montepiedra; Lisa Aaron; Katie McCarthy; Sarah Bradford; Tichaona Vhembo; Lynda Stranix-Chibanda; Gaerolwe R. Masheto; Avy Violari; Blandina T. Mmbaga; Linda Aurpibul; Ramesh Bhosale; Neetal Nevrekhar; Vanessa Rouzier; Enid Kabugho; Mercy Mutambanengwe; Vongai Chanaiwa; Mandisa Nyati; Tsungai Mhembere; Fuanglada Tongprasert; Anneke Hesseling; Katherine Shin; Bonnie Zimmer; Diane Costello; Patrick Jean-Philippe; Timothy R. Sterling; Gerhard Theron; Adriana Weinberg; Amita Gupta; Paolo Denti
1-Sep-2019Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy studyBeatriz Grinsztejn; Michael D. Hughes; Justin Ritz; Robert Salata; Peter Mugyenyi; Evelyn Hogg; Linda Wieclaw; Robert Gross; Catherine Godfrey; Sandra W. Cardoso; Aggrey Bukuru; Mumbi Makanga; Sharlaa Faesen; Vidya Mave; Beatrice Wangari Ndege; Sandy Nerette Fontain; Wadzanai Samaneka; Rode Secours; Marije van Schalkwyk; Rosie Mngqibisa; Lerato Mohapi; Javier Valencia; Patcharaphan Sugandhavesa; Esmelda Montalban; Anchalee Avihingsanon; Breno R. Santos; Nagalingeswaran Kumarasamy; Cecilia Kanyama; Robert T. Schooley; John W. Mellors; Carole L. Wallis; Ann C. Collier; B. Grinsztejn; P. N. Mugyenyi; A. Collier; R. Salata; C. Godfrey; E. Hogg; M. Hughes; J. Ritz; L. Wieclaw; T. Sise; J. W. Mellors; C. Wallis; C. V. Fletcher; M. Gandhi; R. Gross; R. T. Schooley; R. Walensky; M. van Schalkwyk; S. Faesen; R. Mngqibisa; J. Valencia; E. Montalban; N. Kumarasamy; C. Kanyama; S. W. Cardoso; B. R. Santos; B. Mansfield; H. Mugerwa; B. W. Ndege; R. Secours; W. Samaneka; D. Kadam; V. Mave; M. Makanga; S. N. Fontain; P. Sugandhavesa; A. Avihingsanon; L. Nakibuuka; H. Nassolo; P. Anthony; V. Kulkarni; M. Nsubuga; J. van Wyk; J. Rooney; Y. van Delft; R. Leavitt; R. Luk; A. Benns; L. Hovind; A. Shahkolahi
1-Jun-2022Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trialAnchalee Avihingsanon; Michael D. Hughes; Robert Salata; Catherine Godfrey; Caitlyn McCarthy; Peter Mugyenyi; Evelyn Hogg; Robert Gross; Sandra W. Cardoso; Aggrey Bukuru; Mumbi Makanga; Sharlaa Badal-aesen; Vidya Mave; Beatrice Wangari Ndege; Sandy Nerette Fontain; Wadzanai Samaneka; Rode Secours; Marije Van Schalkwyk; Rosie Mngqibisa; Lerato Mohapi; Javier Valencia; Patcharaphan Sugandhavesa; Esmelda Montalban; Cornelius Munyanga; Maganizo Chagomerana; Breno R. Santos; Nagalingeswaran Kumarasamy; Cecilia Kanyama; Robert T. Schooley; John W. Mellors; Carole L. Wallis; Ann C. Collier; Beatriz Grinsztejn
Showing results 1 to 5 of 5